perioperative pain management using a multi- modal approach melanie macinnis; pharmd, rph clinical...

33
Perioperative Pain Management Using a Multi-Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Upload: erick-henry

Post on 25-Dec-2015

216 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Perioperative Pain Management Using a Multi-

Modal Approach

Melanie MacInnis; PharmD, RPhClinical Pharmacist, HHS/McMaster

May 2012

Page 2: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Learning Objectives

• After this presentation, the learner should be able to:– Describe the rationale of multimodal analgesia– Understand the role of acetaminophen, NSAIDs

and gabapentin in post-operative pain control– Determine patient specific factors for prescribing

a multi modal pain control regimen

Page 3: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Pain Definitions

Pain is defined by IASP as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms

of such damage”.

Page 4: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Analgesia Postop Pain

“The major difference between iatrogenic pain and other types of pain is that iatrogenic pain is anticipated. Therefore, the physician has an excellent opportunity to deal with such pain in a planned and expeditious manner.”

Brian Goldman, MD

Page 5: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

The Role of Pain Control in Postoperative Care

• Prevent suffering

• Hasten recovery

• Influence perioperative morbidity

• Decrease the development of chronic pain

Page 6: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Vargas-Shaffer 2010

Page 7: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Chronic Pain Medications• Anti-inflammatories (NSAIDs, steroids)• Muscle relaxants• Benzodiazepines• TCAs and other anti-depressants (SSRIs, SNRIs)• Anticonvulsants (Gabapentin, Pregabalin, Carbamazepine)• Opioids• Tramadol • IV Anti-arrhythmics (lidocaine, bretylium)• Topical formulations (capsaicin, lidocaine, NSAIDs)• Alpha 2-agonists (clonidine, guanethedine)• Cannabinoids (Nabilone)• NMDA antagonists (ketamine, methadone, memantine)• Osteoclast inhibitors (calcitonin, alendronate)

Page 8: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Opioid Tolerance• Shortened duration and decreased intensity of analgesia,

euphoria, sedation, and other CNS effects• Predictable pharmacologic adaptation• Rightward shift in the dose-response curve means increasing

amount of drug to maintain the same effects• In general, the higher the daily dose, the greater the degree

of tolerance • Individuals requiring >1 mg IV (3 mg PO) morphine per hour

for a period of > 1 month are considered to have high-grade tolerance and withdrawal symptoms

World Institute of Pain 2005; 5(1): 18-32

Page 9: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Can J Anesth 2006; 53 (12): 1190-99

Page 10: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Problems of Equi-Analgesic Dose Ratios of Opioids

• Incomplete cross tolerance occurs during chronic opioid use

• Accumulation of active metabolites can influence effect of opioids

• The ratios may change according to the direction of opioid switch

Page 11: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Strategies for Pain Control

• Multimodal analgesia: balanced technique

• Determine and continue baseline opioid requirements, in addition to acute pain requirements

• Treat contributing co-morbidities, such as anxiety, poor sleep, nausea and constipation

• Order pain medications in the acute phase routinely, rather than PRN

Page 12: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

CNS Drugs 2007; 21(3): 185-211

Page 13: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Multi modal analgesia

• Different classes of drugs exert different side effects

• Side effects can be dose related• Additive/synergistic• Combinations can provide superior analgesia

than either drug alone• Opioid sparing• Improved recovery, shorter hospital stay

Page 14: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Acetaminophen

• Very weak COX inhibitor– No appreciable anti-inflammatory or NSAID side

effects• Liver metabolism• 4g/d in healthy adults • Lower doses:

– Liver disease (2g/d)– Alcoholism (2g/d)– Frail elderly (3.2g/d)

Page 15: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

“Tylenol”

• Always confirm with patients• Extra strength tylenol ≠ tylenol with codeine• PRN vs RTC• Acetaminophen as part of multi-modal

analgesia minimizes opioid requirements by 20%

Page 16: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

NSAIDS

• Effective for post operative pain• MOA:

– Inhibit cyclo-oxygenase (COX) in the periphery and spinal column

– Several variants of COX enzyme– Influence platelet function, GI mucosa, and renal

function, CV risk– Selecting the COX variant to avoid side effects

Page 17: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012
Page 18: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Adverse effects

• Platelet dysfunction– NSAIDs alone not a risk for spinal hematoma

• GI ulceration• Nephrotoxicity

• Headache, tinnitus, abdominal pain, rash, hyperkalemia, asthma

Page 19: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Renal function

• Serum creatinine is used as a surrogate• NB: extremes of body weight and

nourishment• Baseline SCr and while on NSAID• Also urea nitrogen, I/O• Cockroft Gault• eGFR

Page 20: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

• SCr = (140-age)(kg) x 0.85 if female(SCr)(72)

http://nephron.com/cgi-bin/CGSI.cgiORwww.globalrph.com (from calculators menu

select CrCl multi-calc under C)

Page 21: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Monitoring for NSAIDs

• CBC (plts), SCr, BUN, lytes

• Absolute contra-indication– GI ulcer, hx of PUD/GUD; CHF; low platelets; CrCl

less than 30ml/min

• Relative contraindication– Fracture, GERD, age

Page 22: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

• Celecoxib: sulfa allergy; only COX-2 selective, 200mg/d max

• Ketorolac: only IV product, po• Ibuprofen: suspension, OTC or rx, po• Naproxen: OTC or rx, po or pr

Page 23: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

NSAIDs + Acetaminophen

• 21 studies• 1909 patients• Ibuprofen, diclofenac, ketorolac, aspirin• Lower pain scores• Lower supplemental analgesic requirements• Better global pain relief

Anesth Analg 2010; 110:1170-9

Page 24: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

NSAIDs + Acetaminophen% more effective Pain intensity

lessenedAnalgesic supplementation lessened

APAP+NSAID 64% 37.7% 31.3%

NSAID

APAP + NSAID 85% 35.0% 38.8%

APAP

Page 25: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

NSAIDs + Acetaminophen

• No evidence of increased side effects• If morphine rescue required; higher incidence

of N/V

Page 26: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Analgesic Efficacy

• NNT calculated for at least 50% pain relief over 4-6h compared to placebo

• Oral, single dose• Moderate to Severe pain• All are oral unless otherwise specified• Doses in mg

Page 27: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Analgesic (mg) NNT

Ibuprofen 600 or 800 1.7

Ibuprofen 400 2.5

Acetaminophen 650 + oxycodone 10 (2 Percocet) 2.6

Ketorolac 10 2.6

Naproxen 500 2.7

Morphine 10mg IV 2.9

Ketorolac 30mg IV 3.4

Acetaminophen 500 3.5

Celecoxib 200 3.5

Acetaminophen 1000 (2 Extra Strength Tylenol) 3.8

Acetaminophen 650 + codeine 60 (2 Tylenol #3) 4.2

Acetaminophen 650 (2 Tylenol Plain) 4.6

Acetaminophen 325 + oxycodone 5 (1 Percocet) 5.5

Acetaminophen 325 + codeine 30 (1 Tylenol #3) 5.7

Codeine 60mg 16.7

Page 28: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Gabapentinoids

• Gabapentin (Neurontin) and pregabalin (Lyrica)• Enhance the inhibitory pain pathway long term• Impact sodium gated channels of nerves in the

periphery• Prevent hyperalgesia postoperatively• Modify transmission of nerve impulses• Can prevent persistent post surgical pain at 3-6

months

Page 29: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Gabapentinoids

• Role in post-operative treatment is unclear• Can reduce pain intensity and opioid

consumption• Optimal dose and duration unknown

– Gabapentin: 300-1200mg pre op, post op 100-300mg variety of dosing strategies

– Pregabalin: 150-300mg pre-op, post op doses 50mg-150mg of durations 24h – 2 weeks

• No influence on prevention of PONV

Page 30: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Gabapentinoids

• Renally eliminated• SCr needed baseline and after initiation• Dose reduction in renal impairment• After long term use needs to be tapered to DC

(seizure risk)• In elderly can cause confusion, sedation,

dysphoria

Page 31: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Take Home Points

• Multimodal analgesia can help improve pain control and minimize side effects

• Persistent postsurgical pain may be influenced by improved acute pain control

• Order routine pain medications initially for moderate to severe pain (rather than PRN)

Page 32: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Take Home Points

• Patient specific factors need to be considered in prescribing the best post-operative analgesic regimen

• Around the clock NSAIDS + acetaminophen are effective and minimize opioid use

• The role of gabapentinoids is unclear in post operative pain control

Page 33: Perioperative Pain Management Using a Multi- Modal Approach Melanie MacInnis; PharmD, RPh Clinical Pharmacist, HHS/McMaster May 2012

Thank you.

Questions and Comments.